Bristol Myers Squibb Co. (BMY)
67.31
+0.30
(+0.45%)
USD |
NYSE |
Aug 24, 16:00
67.13
-0.18
(-0.27%)
After-Hours: 19:58
Bristol Myers Squibb Max Drawdown (5Y) : 47.67% for July 31, 2026
Max Drawdown (5Y) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| July 31, 2026 | 47.67% |
| June 30, 2026 | 47.67% |
| May 31, 2026 | 47.67% |
| April 30, 2026 | 47.67% |
| March 31, 2026 | 47.67% |
| February 28, 2026 | 47.67% |
| January 31, 2026 | 47.67% |
| December 31, 2025 | 47.67% |
| November 30, 2025 | 47.67% |
| October 31, 2025 | 47.67% |
| September 30, 2025 | 47.67% |
| August 31, 2025 | 47.67% |
| July 31, 2025 | 47.67% |
| June 30, 2025 | 47.67% |
| May 31, 2025 | 47.67% |
| April 30, 2025 | 47.67% |
| March 31, 2025 | 47.67% |
| February 28, 2025 | 47.67% |
| January 31, 2025 | 47.67% |
| December 31, 2024 | 47.67% |
| November 30, 2024 | 47.67% |
| October 31, 2024 | 47.67% |
| September 30, 2024 | 47.67% |
| August 31, 2024 | 47.67% |
| July 31, 2024 | 47.67% |
| Date | Value |
|---|---|
| June 30, 2024 | 47.43% |
| May 31, 2024 | 47.43% |
| April 30, 2024 | 42.61% |
| March 31, 2024 | 39.24% |
| February 29, 2024 | 39.24% |
| January 31, 2024 | 39.24% |
| December 31, 2023 | 39.24% |
| November 30, 2023 | 39.24% |
| October 31, 2023 | 39.24% |
| September 30, 2023 | 39.24% |
| August 31, 2023 | 39.24% |
| July 31, 2023 | 39.24% |
| June 30, 2023 | 39.24% |
| May 31, 2023 | 39.24% |
| April 30, 2023 | 39.24% |
| March 31, 2023 | 39.24% |
| February 28, 2023 | 39.24% |
| January 31, 2023 | 39.24% |
| December 31, 2022 | 39.24% |
| November 30, 2022 | 39.24% |
| October 31, 2022 | 39.24% |
| September 30, 2022 | 39.24% |
| August 31, 2022 | 39.24% |
| July 31, 2022 | 39.24% |
| June 30, 2022 | 39.24% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| Johnson & Johnson | 18.44% |
| Eli Lilly & Co. | 34.47% |
| Merck & Co., Inc. | 43.45% |
| Pfizer Inc. | 58.95% |
| AstraZeneca PLC | 27.87% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -2.305 |
| Beta (5Y) | 0.2208 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 23.65% |
| Historical Sharpe Ratio (5Y) | -0.0115 |
| Historical Sortino (5Y) | -0.0202 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 10.18% |